Pre-Election Special SALE: 60% Off VIP Membership
BREAKING: Supreme Court Rules on Whether Virginia Can Remove Non-Citizens From Voter Rolls
Tim Walz's Gaming Session With Ocasio-Cortez Was a Trainwreck
Oregon Predicates Request to Judge on Self-Delusion
GDP Report Shows Economy 'Weaker Than Expected'
How Trump Plans to Help Compensate Victims of 'Migrant Crime'
NRCC Blasts the Left's Voter Suppression Efforts in Battleground Districts
Watch Trump's Reaction to Finding Out Biden Called His Supporters 'Garbage'
26 Republican AGs Join Virginia in Petitioning SCOTUS to Intervene in Voter Registration...
There Was a Vile, Violent Attack in Chicago, and the Media's Been Silent....
One Red State Just Acquired a Massive Amount of Land to Secure Its...
Poll Out of Texas Shows That Harris Rally Sure Didn't Work for Colin...
This Hollywood Actor Is Persuading Christian Men to Vote for Kamala Harris
Is the Trump Campaign Over-Confident?
Is This Really How the Kamala HQ Is Going to Respond to Biden’s...
OPINION

Yield Curves Are Close To Being Inverted (Some Say That's A Recession Predictor)

The opinions expressed by columnists are their own and do not necessarily represent the views of Townhall.com.
Advertisement
Advertisement
Advertisement

It was another solid week for the market, even remarkable when you consider how far and how fast the market has rallied in 2019. The most impressive part of the rally is how well the market has begun this year. This is the first time the market has rallied eight straight weeks at the start of the year since 1964. Friday’s session saw Technology come on strong, but it was led by Intuit (INTU) and Western Digital (WDC) and Xilinx (XLNX).

Advertisement

Auto dealer Copart (CPRT)) led Consumer Discretionary stocks, even as many of its rivals were hammered during the week. 

S&P 500 Index

+0.64%

Communication Services (XLC)

+0.94%

Consumer Discretionary (XLY)

+0.54%

Consumer Staples (XLP)

-0.48%

Energy (XLE)

+0.29%

Financials (XLF)

-0.15%

Health Care (XLV)

+0.92%

Industrials (XLI)

+0.66%

Materials (XLB)

+0.43%

Real Estate (XLRE)

+0.57%

Technology (XLK)

+1.28%

Utilities (XLU)

+0.62%

 

Same Tide

There is an old saying about the same tide lifting all ships, and that has been the case for all investment classes in 2019. Crude oil continues to edge higher and has been among the best investments of the year. I continue to pound the table on small-cap names in the Russell 2000. It’s where all the grand slams trade these days. 

Index/Asset

Feb 22, 2019

Year to Date

Dow Jones Industrial Average

+0.70%

+11.6%

S&P 500

+0.64%

+11.4%

NASDAQ Composite

+0.91%

+13.5%

Russell 2000

+0.92%

+17.9%

Dow Jones Transportation

-0.37%

+15.6%

Philly Semiconductor Index

+1.08%

+18.1%

Crude Oil

+0.19%

+22.7%

 

There is still a fair amount of grumbling about the yield curve, which is this close to inverting. Keep in mind: in the past, inverted yield curves predicted recessions, but by an average of 18 months later.  I think any hysterics around inversion has created a buying opportunity, as bears scream for the end is nigh.

Advertisement

Portfolio Approach

On Friday, we added another idea in the model portfolio to Consumer Discretionary, which brings it to a four weighting, matching the Industrials and Material sectors.

Make sure you understand our Portfolio Approach and our online position tracker. Check with your rep or research@wstreet.com.

Communication Services

Consumer Discretionary

Consumer Staples

1

4

1

Energy

Financials

Healthcare

1

1

1

Industrial

Materials

Real Estate

4

4

0

Technology

Utilities

Cash

2

0

1

Today’s Session

Two Big Deals

GE is selling its Life Science business to Danaher for $21.4 billion ($21.0 billion in cash).  It’s a great deal for both companies and shares of both are indicating higher.

Note: Danaher was once a mortgage company.  Management adopted the “kaizen” Japanese business philosophy and has been reinventing itself for a couple of decades.  Last year, Life Sciences became the largest biggest segment and enjoyed a sharp increase in operating margin.

 

Danaher (DHR)

Revenue

2018

in billions

2017

In billions

Life Sciences

$6.47

$5.71

Diagnostics

$6.26

$5.84

Environmental

$4.37

$3.97

Dental

$2.84

$2.81

 

Danaher (DHR)

Op Margins

2018

2017

Life Sciences

19.0

17.6

Diagnostics

17.2

14.9

Environmental

22.9

23.0

Dental

12.2

14.3

Advertisement

 

Spark Therapeutics is being bought by Roche for $4.8 billion.  The Philadelphia based company is the first to receive approval for gene therapy.  Its treatment for Luxturna, a rare form of blindness that affects up to 2000 US Patients, has unleashed a wave of excitement about additional applications.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos